Nuclear Factor-Kappa-B Mediates the Advanced Glycation End Product-Induced Repression of Slc2a4 Gene Expression in 3T3-L1 Adipocytes
Advanced glycated end products (AGEs) are cytotoxic compounds that are mainly increased in diabetes mellitus (DM), kidney failure, inflammation, and in response to the ingestion of AGE-rich diets. AGEs can also impair glycemic homeostasis by decreasing the expression of the (solute carrier family 2...
Gespeichert in:
Veröffentlicht in: | International journal of molecular sciences 2024-08, Vol.25 (15), p.8242 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 15 |
container_start_page | 8242 |
container_title | International journal of molecular sciences |
container_volume | 25 |
creator | Michalani, Maria Luiza Estimo Passarelli, Marisa Machado, Ubiratan Fabres |
description | Advanced glycated end products (AGEs) are cytotoxic compounds that are mainly increased in diabetes mellitus (DM), kidney failure, inflammation, and in response to the ingestion of AGE-rich diets. AGEs can also impair glycemic homeostasis by decreasing the expression of the
(solute carrier family 2 member 4) gene and its GLUT4 (solute carrier family 2, facilitated glucose transporter member 4) protein in muscle. However, the mechanisms underlying AGE's effect on adipocytes have not been demonstrated yet. This study investigated the effects of AGEs upon
/GLUT4 expression in 3T3-L1 adipocytes, as well as the potential role of NFKB (nuclear factor NF-kappa-B) activity in the effects observed. Adipocytes were cultured in the presence of control albumin (CA) or advanced glycated albumin (GA) at concentrations of 0.4, 3.6, and 5.4 mg/mL for 24 h or 72 h.
,
and
mRNAs were measured by RT-qPCR, GLUT4, IKKA/B, and p50/p65 NFKB subunits using Western blotting, and p50/p65 binding into the
promoter was analyzed by chromatin immunoprecipitation (ChIP) assay. GA at 0.4 mg/mL increased
/GLUT4 expression after 24 h and 72 h (from 50% to 100%), but at 5.4 mg/mL,
/GLUT4 expression decreased at 72 h (by 50%).
and
expression increased after 24 h at all concentrations, but this effect was not observed at 72 h. Furthermore, 5.4 mg/mL of GA increased the p50/p65 nuclear content and binding into
at 72 h. In summary, this study reveals AGE-induced and NFKB-mediated repression of
/GLUT4 expression. This can compromise the adipocyte glucose utilization, contributing not only to the worsening of glycemic control in DM subjects but also the impairment of glycemic homeostasis in non-DM subjects under the high intake of AGE-rich foods. |
doi_str_mv | 10.3390/ijms25158242 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_3091287489</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A804511435</galeid><sourcerecordid>A804511435</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-20abe17f916fb5d64efd0e2e12dd02eda7e520c4b460d4fec43d2f2474e5c8033</originalsourceid><addsrcrecordid>eNptkc1v1DAQxS0EoqVw44wsceFAij22N8lxqbZLxfIhKOfIa4_Bq8RO7QSxd_5wvGopBSEfxvL7zZuRHyFPOTsVomWv_G7IoLhqQMI9cswlQMXYor5_535EHuW8YwwEqPYhORItB9Vwfkx-vp9NjzrRc22mmKq3ehx19Zq-Q-v1hJlO35Au7XcdDFq67vdGTz4GugqWfkzRzmaqLkIpRf2EY8KcD3J09HNvQEu6xoB09eNW8YGKS1FteHH1YzT7MuQxeeB0n_HJTT0hX85Xl2dvqs2H9cXZclMZwflUAdNb5LVr-cJtlV1IdJYhIAdrGaDVNSpgRm7lglnp0EhhwYGsJSrTMCFOyItr3zHFqxnz1A0-G-x7HTDOuROs_EtTy6Yt6PN_0F2cUyjbHSjWSikA_lBfdY-dDy5OSZuDabdsmFScS6EKdfofqhyLgzcxoPPl_a-Gl9cNJsWcE7puTH7Qad9x1h1C7-6GXvBnN7vO2wHtLfw7ZfELsQSlOw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3090944322</pqid></control><display><type>article</type><title>Nuclear Factor-Kappa-B Mediates the Advanced Glycation End Product-Induced Repression of Slc2a4 Gene Expression in 3T3-L1 Adipocytes</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>PubMed Central</source><creator>Michalani, Maria Luiza Estimo ; Passarelli, Marisa ; Machado, Ubiratan Fabres</creator><creatorcontrib>Michalani, Maria Luiza Estimo ; Passarelli, Marisa ; Machado, Ubiratan Fabres</creatorcontrib><description>Advanced glycated end products (AGEs) are cytotoxic compounds that are mainly increased in diabetes mellitus (DM), kidney failure, inflammation, and in response to the ingestion of AGE-rich diets. AGEs can also impair glycemic homeostasis by decreasing the expression of the
(solute carrier family 2 member 4) gene and its GLUT4 (solute carrier family 2, facilitated glucose transporter member 4) protein in muscle. However, the mechanisms underlying AGE's effect on adipocytes have not been demonstrated yet. This study investigated the effects of AGEs upon
/GLUT4 expression in 3T3-L1 adipocytes, as well as the potential role of NFKB (nuclear factor NF-kappa-B) activity in the effects observed. Adipocytes were cultured in the presence of control albumin (CA) or advanced glycated albumin (GA) at concentrations of 0.4, 3.6, and 5.4 mg/mL for 24 h or 72 h.
,
and
mRNAs were measured by RT-qPCR, GLUT4, IKKA/B, and p50/p65 NFKB subunits using Western blotting, and p50/p65 binding into the
promoter was analyzed by chromatin immunoprecipitation (ChIP) assay. GA at 0.4 mg/mL increased
/GLUT4 expression after 24 h and 72 h (from 50% to 100%), but at 5.4 mg/mL,
/GLUT4 expression decreased at 72 h (by 50%).
and
expression increased after 24 h at all concentrations, but this effect was not observed at 72 h. Furthermore, 5.4 mg/mL of GA increased the p50/p65 nuclear content and binding into
at 72 h. In summary, this study reveals AGE-induced and NFKB-mediated repression of
/GLUT4 expression. This can compromise the adipocyte glucose utilization, contributing not only to the worsening of glycemic control in DM subjects but also the impairment of glycemic homeostasis in non-DM subjects under the high intake of AGE-rich foods.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms25158242</identifier><identifier>PMID: 39125811</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>3T3-L1 Cells ; Adipocytes ; Adipocytes - drug effects ; Adipocytes - metabolism ; Age ; Animals ; Biotechnology industry ; Body fat ; Dextrose ; Diabetes ; Ethylenediaminetetraacetic acid ; Gene expression ; Gene Expression Regulation - drug effects ; Glucose ; Glucose Transporter Type 4 - genetics ; Glucose Transporter Type 4 - metabolism ; Glycation End Products, Advanced - metabolism ; Glycation End Products, Advanced - pharmacology ; Homeostasis ; Insulin resistance ; Kinases ; Localization ; Mice ; Musculoskeletal system ; Neurophysiology ; NF-kappa B - metabolism ; NF-kappa B p50 Subunit - genetics ; NF-kappa B p50 Subunit - metabolism ; Oxidative stress ; Phosphorylation ; Promoter Regions, Genetic ; Proteins ; Transcription Factor RelA - genetics ; Transcription Factor RelA - metabolism</subject><ispartof>International journal of molecular sciences, 2024-08, Vol.25 (15), p.8242</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c311t-20abe17f916fb5d64efd0e2e12dd02eda7e520c4b460d4fec43d2f2474e5c8033</cites><orcidid>0000-0002-7914-0107 ; 0000-0002-8237-2435 ; 0000-0002-9249-4698</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39125811$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Michalani, Maria Luiza Estimo</creatorcontrib><creatorcontrib>Passarelli, Marisa</creatorcontrib><creatorcontrib>Machado, Ubiratan Fabres</creatorcontrib><title>Nuclear Factor-Kappa-B Mediates the Advanced Glycation End Product-Induced Repression of Slc2a4 Gene Expression in 3T3-L1 Adipocytes</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Advanced glycated end products (AGEs) are cytotoxic compounds that are mainly increased in diabetes mellitus (DM), kidney failure, inflammation, and in response to the ingestion of AGE-rich diets. AGEs can also impair glycemic homeostasis by decreasing the expression of the
(solute carrier family 2 member 4) gene and its GLUT4 (solute carrier family 2, facilitated glucose transporter member 4) protein in muscle. However, the mechanisms underlying AGE's effect on adipocytes have not been demonstrated yet. This study investigated the effects of AGEs upon
/GLUT4 expression in 3T3-L1 adipocytes, as well as the potential role of NFKB (nuclear factor NF-kappa-B) activity in the effects observed. Adipocytes were cultured in the presence of control albumin (CA) or advanced glycated albumin (GA) at concentrations of 0.4, 3.6, and 5.4 mg/mL for 24 h or 72 h.
,
and
mRNAs were measured by RT-qPCR, GLUT4, IKKA/B, and p50/p65 NFKB subunits using Western blotting, and p50/p65 binding into the
promoter was analyzed by chromatin immunoprecipitation (ChIP) assay. GA at 0.4 mg/mL increased
/GLUT4 expression after 24 h and 72 h (from 50% to 100%), but at 5.4 mg/mL,
/GLUT4 expression decreased at 72 h (by 50%).
and
expression increased after 24 h at all concentrations, but this effect was not observed at 72 h. Furthermore, 5.4 mg/mL of GA increased the p50/p65 nuclear content and binding into
at 72 h. In summary, this study reveals AGE-induced and NFKB-mediated repression of
/GLUT4 expression. This can compromise the adipocyte glucose utilization, contributing not only to the worsening of glycemic control in DM subjects but also the impairment of glycemic homeostasis in non-DM subjects under the high intake of AGE-rich foods.</description><subject>3T3-L1 Cells</subject><subject>Adipocytes</subject><subject>Adipocytes - drug effects</subject><subject>Adipocytes - metabolism</subject><subject>Age</subject><subject>Animals</subject><subject>Biotechnology industry</subject><subject>Body fat</subject><subject>Dextrose</subject><subject>Diabetes</subject><subject>Ethylenediaminetetraacetic acid</subject><subject>Gene expression</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Glucose</subject><subject>Glucose Transporter Type 4 - genetics</subject><subject>Glucose Transporter Type 4 - metabolism</subject><subject>Glycation End Products, Advanced - metabolism</subject><subject>Glycation End Products, Advanced - pharmacology</subject><subject>Homeostasis</subject><subject>Insulin resistance</subject><subject>Kinases</subject><subject>Localization</subject><subject>Mice</subject><subject>Musculoskeletal system</subject><subject>Neurophysiology</subject><subject>NF-kappa B - metabolism</subject><subject>NF-kappa B p50 Subunit - genetics</subject><subject>NF-kappa B p50 Subunit - metabolism</subject><subject>Oxidative stress</subject><subject>Phosphorylation</subject><subject>Promoter Regions, Genetic</subject><subject>Proteins</subject><subject>Transcription Factor RelA - genetics</subject><subject>Transcription Factor RelA - metabolism</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkc1v1DAQxS0EoqVw44wsceFAij22N8lxqbZLxfIhKOfIa4_Bq8RO7QSxd_5wvGopBSEfxvL7zZuRHyFPOTsVomWv_G7IoLhqQMI9cswlQMXYor5_535EHuW8YwwEqPYhORItB9Vwfkx-vp9NjzrRc22mmKq3ehx19Zq-Q-v1hJlO35Au7XcdDFq67vdGTz4GugqWfkzRzmaqLkIpRf2EY8KcD3J09HNvQEu6xoB09eNW8YGKS1FteHH1YzT7MuQxeeB0n_HJTT0hX85Xl2dvqs2H9cXZclMZwflUAdNb5LVr-cJtlV1IdJYhIAdrGaDVNSpgRm7lglnp0EhhwYGsJSrTMCFOyItr3zHFqxnz1A0-G-x7HTDOuROs_EtTy6Yt6PN_0F2cUyjbHSjWSikA_lBfdY-dDy5OSZuDabdsmFScS6EKdfofqhyLgzcxoPPl_a-Gl9cNJsWcE7puTH7Qad9x1h1C7-6GXvBnN7vO2wHtLfw7ZfELsQSlOw</recordid><startdate>20240801</startdate><enddate>20240801</enddate><creator>Michalani, Maria Luiza Estimo</creator><creator>Passarelli, Marisa</creator><creator>Machado, Ubiratan Fabres</creator><general>MDPI AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7914-0107</orcidid><orcidid>https://orcid.org/0000-0002-8237-2435</orcidid><orcidid>https://orcid.org/0000-0002-9249-4698</orcidid></search><sort><creationdate>20240801</creationdate><title>Nuclear Factor-Kappa-B Mediates the Advanced Glycation End Product-Induced Repression of Slc2a4 Gene Expression in 3T3-L1 Adipocytes</title><author>Michalani, Maria Luiza Estimo ; Passarelli, Marisa ; Machado, Ubiratan Fabres</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-20abe17f916fb5d64efd0e2e12dd02eda7e520c4b460d4fec43d2f2474e5c8033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>3T3-L1 Cells</topic><topic>Adipocytes</topic><topic>Adipocytes - drug effects</topic><topic>Adipocytes - metabolism</topic><topic>Age</topic><topic>Animals</topic><topic>Biotechnology industry</topic><topic>Body fat</topic><topic>Dextrose</topic><topic>Diabetes</topic><topic>Ethylenediaminetetraacetic acid</topic><topic>Gene expression</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Glucose</topic><topic>Glucose Transporter Type 4 - genetics</topic><topic>Glucose Transporter Type 4 - metabolism</topic><topic>Glycation End Products, Advanced - metabolism</topic><topic>Glycation End Products, Advanced - pharmacology</topic><topic>Homeostasis</topic><topic>Insulin resistance</topic><topic>Kinases</topic><topic>Localization</topic><topic>Mice</topic><topic>Musculoskeletal system</topic><topic>Neurophysiology</topic><topic>NF-kappa B - metabolism</topic><topic>NF-kappa B p50 Subunit - genetics</topic><topic>NF-kappa B p50 Subunit - metabolism</topic><topic>Oxidative stress</topic><topic>Phosphorylation</topic><topic>Promoter Regions, Genetic</topic><topic>Proteins</topic><topic>Transcription Factor RelA - genetics</topic><topic>Transcription Factor RelA - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Michalani, Maria Luiza Estimo</creatorcontrib><creatorcontrib>Passarelli, Marisa</creatorcontrib><creatorcontrib>Machado, Ubiratan Fabres</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Michalani, Maria Luiza Estimo</au><au>Passarelli, Marisa</au><au>Machado, Ubiratan Fabres</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nuclear Factor-Kappa-B Mediates the Advanced Glycation End Product-Induced Repression of Slc2a4 Gene Expression in 3T3-L1 Adipocytes</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2024-08-01</date><risdate>2024</risdate><volume>25</volume><issue>15</issue><spage>8242</spage><pages>8242-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Advanced glycated end products (AGEs) are cytotoxic compounds that are mainly increased in diabetes mellitus (DM), kidney failure, inflammation, and in response to the ingestion of AGE-rich diets. AGEs can also impair glycemic homeostasis by decreasing the expression of the
(solute carrier family 2 member 4) gene and its GLUT4 (solute carrier family 2, facilitated glucose transporter member 4) protein in muscle. However, the mechanisms underlying AGE's effect on adipocytes have not been demonstrated yet. This study investigated the effects of AGEs upon
/GLUT4 expression in 3T3-L1 adipocytes, as well as the potential role of NFKB (nuclear factor NF-kappa-B) activity in the effects observed. Adipocytes were cultured in the presence of control albumin (CA) or advanced glycated albumin (GA) at concentrations of 0.4, 3.6, and 5.4 mg/mL for 24 h or 72 h.
,
and
mRNAs were measured by RT-qPCR, GLUT4, IKKA/B, and p50/p65 NFKB subunits using Western blotting, and p50/p65 binding into the
promoter was analyzed by chromatin immunoprecipitation (ChIP) assay. GA at 0.4 mg/mL increased
/GLUT4 expression after 24 h and 72 h (from 50% to 100%), but at 5.4 mg/mL,
/GLUT4 expression decreased at 72 h (by 50%).
and
expression increased after 24 h at all concentrations, but this effect was not observed at 72 h. Furthermore, 5.4 mg/mL of GA increased the p50/p65 nuclear content and binding into
at 72 h. In summary, this study reveals AGE-induced and NFKB-mediated repression of
/GLUT4 expression. This can compromise the adipocyte glucose utilization, contributing not only to the worsening of glycemic control in DM subjects but also the impairment of glycemic homeostasis in non-DM subjects under the high intake of AGE-rich foods.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>39125811</pmid><doi>10.3390/ijms25158242</doi><orcidid>https://orcid.org/0000-0002-7914-0107</orcidid><orcidid>https://orcid.org/0000-0002-8237-2435</orcidid><orcidid>https://orcid.org/0000-0002-9249-4698</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1422-0067 |
ispartof | International journal of molecular sciences, 2024-08, Vol.25 (15), p.8242 |
issn | 1422-0067 1661-6596 1422-0067 |
language | eng |
recordid | cdi_proquest_miscellaneous_3091287489 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; MDPI - Multidisciplinary Digital Publishing Institute; PubMed Central |
subjects | 3T3-L1 Cells Adipocytes Adipocytes - drug effects Adipocytes - metabolism Age Animals Biotechnology industry Body fat Dextrose Diabetes Ethylenediaminetetraacetic acid Gene expression Gene Expression Regulation - drug effects Glucose Glucose Transporter Type 4 - genetics Glucose Transporter Type 4 - metabolism Glycation End Products, Advanced - metabolism Glycation End Products, Advanced - pharmacology Homeostasis Insulin resistance Kinases Localization Mice Musculoskeletal system Neurophysiology NF-kappa B - metabolism NF-kappa B p50 Subunit - genetics NF-kappa B p50 Subunit - metabolism Oxidative stress Phosphorylation Promoter Regions, Genetic Proteins Transcription Factor RelA - genetics Transcription Factor RelA - metabolism |
title | Nuclear Factor-Kappa-B Mediates the Advanced Glycation End Product-Induced Repression of Slc2a4 Gene Expression in 3T3-L1 Adipocytes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T13%3A47%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nuclear%20Factor-Kappa-B%20Mediates%20the%20Advanced%20Glycation%20End%20Product-Induced%20Repression%20of%20Slc2a4%20Gene%20Expression%20in%203T3-L1%20Adipocytes&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Michalani,%20Maria%20Luiza%20Estimo&rft.date=2024-08-01&rft.volume=25&rft.issue=15&rft.spage=8242&rft.pages=8242-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms25158242&rft_dat=%3Cgale_proqu%3EA804511435%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3090944322&rft_id=info:pmid/39125811&rft_galeid=A804511435&rfr_iscdi=true |